Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene for Hypogonadotropic Hypogonadism in Obese Young Males
NCT03245827Phase 2Terminated
- Start
- Apr 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clomiphene in hypogonadotropic hypogonadism (HH) (4 arms). Primary endpoint: Serum Free Testosterone at 12 weeks. Started Apr 2019; status: terminated.
02
Drugs
clomiphene
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT03245827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245827.